Literature DB >> 28373189

Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria.

Joshua T Thaden1, Lawrence P Park1, Stacey A Maskarinec1, Felicia Ruffin1, Vance G Fowler2, David van Duin3.   

Abstract

The impact of bacterial species on outcome in bloodstream infections (BSI) is incompletely understood. We evaluated the impact of bacterial species on BSI mortality, with adjustment for patient, bacterial, and treatment factors. From 2002 to 2015, all adult inpatients with monomicrobial BSI caused by Staphylococcus aureus or Gram-negative bacteria at Duke University Medical Center were prospectively enrolled. Kaplan-Meier curves and multivariable Cox regression with propensity score models were used to examine species-specific bacterial BSI mortality. Of the 2,659 enrolled patients, 999 (38%) were infected with S. aureus, and 1,660 (62%) were infected with Gram-negative bacteria. Among patients with Gram-negative BSI, Enterobacteriaceae (81% [1,343/1,660]) were most commonly isolated, followed by non-lactose-fermenting Gram-negative bacteria (16% [262/1,660]). Of the 999 S. aureus BSI isolates, 507 (51%) were methicillin resistant. Of the 1,660 Gram-negative BSI isolates, 500 (30%) were multidrug resistant. The unadjusted time-to-mortality among patients with Gram-negative BSI was shorter than that of patients with S. aureus BSI (P = 0.003), due to increased mortality in patients with non-lactose-fermenting Gram-negative BSI generally (P < 0.0001) and Pseudomonas aeruginosa BSI (n = 158) in particular (P < 0.0001). After adjustment for patient demographics, medical comorbidities, bacterial antibiotic resistance, timing of appropriate antibiotic therapy, and source control in patients with line-associated BSI, P. aeruginosa BSI remained significantly associated with increased mortality (hazard ratio = 1.435; 95% confidence interval = 1.043 to 1.933; P = 0.02). P. aeruginosa BSI was associated with increased mortality relative to S. aureus or other Gram-negative BSI. This effect persisted after adjustment for patient, bacterial, and treatment factors.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Gram negative; Pseudomonas aeruginosa; Staphylococcus aureus; bloodstream infections

Mesh:

Year:  2017        PMID: 28373189      PMCID: PMC5444115          DOI: 10.1128/AAC.02671-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.

Authors:  Marie-Laurence Lambert; Carl Suetens; Anne Savey; Mercedes Palomar; Michael Hiesmayr; Ingrid Morales; Antonella Agodi; Uwe Frank; Karl Mertens; Martin Schumacher; Martin Wolkewitz
Journal:  Lancet Infect Dis       Date:  2010-12-02       Impact factor: 25.071

2.  Community-onset bacteraemia of unknown origin: clinical characteristics, epidemiology and outcome.

Authors:  C Hernandez; N Cobos-Trigueros; C Feher; L Morata; C De La Calle; F Marco; M Almela; A Soriano; J Mensa; A Del Rio; J A Martinez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-08       Impact factor: 3.267

3.  Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study.

Authors:  Alexandre R Marra; Luis Fernando Aranha Camargo; Antonio Carlos Campos Pignatari; Teresa Sukiennik; Paulo Renato Petersen Behar; Eduardo Alexandrino Servolo Medeiros; Julival Ribeiro; Evelyne Girão; Luci Correa; Carla Guerra; Carlos Brites; Carlos Alberto Pires Pereira; Irna Carneiro; Marise Reis; Marta Antunes de Souza; Regina Tranchesi; Cristina U Barata; Michael B Edmond
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

4.  Derivation of a clinical prediction rule for bloodstream infection mortality of patients visiting the emergency department based on predisposition, infection, response, and organ dysfunction concept.

Authors:  Chun-Fu Yeh; Kuan-Fu Chen; Jung-Jr Ye; Ching-Tai Huang
Journal:  J Microbiol Immunol Infect       Date:  2013-08-19       Impact factor: 4.399

5.  Efficacy of the Novel Antibiotic POL7001 in Preclinical Models of Pseudomonas aeruginosa Pneumonia.

Authors:  Cristina Cigana; Francesca Bernardini; Marcella Facchini; Beatriz Alcalá-Franco; Camilla Riva; Ida De Fino; Alice Rossi; Serena Ranucci; Pauline Misson; Eric Chevalier; Maj Brodmann; Michel Schmitt; Achim Wach; Glenn E Dale; Daniel Obrecht; Alessandra Bragonzi
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

6.  Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes.

Authors:  J Bisbe; J M Gatell; J Puig; J Mallolas; J A Martinez; M T Jimenez de Anta; E Soriano
Journal:  Rev Infect Dis       Date:  1988 May-Jun

7.  Epidemiology and outcome of nosocomial and community-onset bloodstream infection.

Authors:  D J Diekema; S E Beekmann; K C Chapin; K A Morel; E Munson; G V Doern
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

8.  Predictors of mortality among bacteremic patients with septic shock receiving appropriate antimicrobial therapy.

Authors:  David D Leedahl; Heather A Personett; Ognjen Gajic; Rahul Kashyap; Garrett E Schramm
Journal:  BMC Anesthesiol       Date:  2014-03-25       Impact factor: 2.217

9.  Intensive care unit-acquired bacteremia in mechanically ventilated patients: clinical features and outcomes.

Authors:  Hsin-Kuo Ko; Wen-Kuang Yu; Te-Cheng Lien; Jia-Horng Wang; Arthur S Slutsky; Haibo Zhang; Yu Ru Kou
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

10.  Factors influencing the early mortality in haematological malignancy patients with nosocomial Gram negative bacilli bacteraemia: a retrospective analysis of 154 cases.

Authors:  Gökhan Metan; Hayati Demiraslan; Leyla Gül Kaynar; Gökmen Zararsız; Emine Alp; Bülent Eser
Journal:  Braz J Infect Dis       Date:  2013-02-26       Impact factor: 3.257

View more
  35 in total

1.  Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa and Impact of Antimicrobial Resistance and Bacterial Virulence.

Authors:  Raúl Recio; Mikel Mancheño; Esther Viedma; Jennifer Villa; María Ángeles Orellana; Jaime Lora-Tamayo; Fernando Chaves
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

2.  Newly Named Klebsiella aerogenes (formerly Enterobacter aerogenes) Is Associated with Poor Clinical Outcomes Relative to Other Enterobacter Species in Patients with Bloodstream Infection.

Authors:  Austin Wesevich; Granger Sutton; Felicia Ruffin; Lawrence P Park; Derrick E Fouts; Vance G Fowler; Joshua T Thaden
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

3.  Pharmacodynamic Evaluation of Plasma and Epithelial Lining Fluid Exposures of Amikacin against Pseudomonas aeruginosa in a Dynamic In Vitro Hollow-Fiber Infection Model.

Authors:  Aaron J Heffernan; Fekade B Sime; Derek S Sarovich; Michael Neely; Yarmarly Guerra-Valero; Saiyuri Naicker; Kyra Cottrell; Patrick Harris; Katherine T Andrews; David Ellwood; Steven C Wallis; Jeffrey Lipman; Keith Grimwood; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

4.  Emergence of Ceftolozane-Tazobactam-Resistant Pseudomonas aeruginosa during Treatment Is Mediated by a Single AmpC Structural Mutation.

Authors:  Shawn H MacVane; Ruchi Pandey; Lisa L Steed; Barry N Kreiswirth; Liang Chen
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

5.  Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients.

Authors:  Rajbharan Yadav; Phillip J Bergen; Kate E Rogers; Carl M J Kirkpatrick; Steven C Wallis; Yuling Huang; Jürgen B Bulitta; David L Paterson; Jeffrey Lipman; Roger L Nation; Jason A Roberts; Cornelia B Landersdorfer
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

6.  Evaluation of the Accelerate Pheno™ system for rapid identification and antimicrobial susceptibility testing of Gram-negative bacteria in bloodstream infections.

Authors:  Ghislaine Descours; Laurent Desmurs; Thi Lam Thuy Hoang; Marine Ibranosyan; Maud Baume; Anne-Gaëlle Ranc; Christine Fuhrmann; Olivier Dauwalder; Waël Salka; François Vandenesch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-28       Impact factor: 3.267

7.  Pathogenic characteristics of Pseudomonas aeruginosa bacteraemia isolates in a high-endemicity setting for ST175 and ST235 high-risk clones.

Authors:  Raúl Recio; Irina Sánchez-Diener; Esther Viedma; María Ángeles Meléndez-Carmona; Jennifer Villa; María Ángeles Orellana; Mikel Mancheño; Carlos Juan; Laura Zamorano; Jaime Lora-Tamayo; Fernando Chaves; Antonio Oliver
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-10       Impact factor: 3.267

8.  Adding Insult to Injury: Mechanistic Basis for How AmpC Mutations Allow Pseudomonas aeruginosa To Accelerate Cephalosporin Hydrolysis and Evade Avibactam.

Authors:  Cole L Slater; Judith Winogrodzki; Pablo A Fraile-Ribot; Antonio Oliver; Mazdak Khajehpour; Brian L Mark
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

9.  Potent Killing of Pseudomonas aeruginosa by an Antibody-Antibiotic Conjugate.

Authors:  Kimberly K Kajihara; Homer Pantua; Hilda Hernandez-Barry; Meredith Hazen; Kiran Deshmukh; Nancy Chiang; Rachana Ohri; Erick R Castellanos; Lynn Martin; Marissa L Matsumoto; Jian Payandeh; Kelly M Storek; Kellen Schneider; Peter A Smith; Michael F T Koehler; Siao Ping Tsai; Richard Vandlen; Kelly M Loyet; Gerald Nakamura; Thomas Pillow; Dhaya Seshasayee; Sharookh B Kapadia; Wouter L W Hazenbos
Journal:  mBio       Date:  2021-06-01       Impact factor: 7.867

Review 10.  An Organ System-Based Synopsis of Pseudomonas aeruginosa Virulence.

Authors:  Charles D Morin; Eric Déziel; Jeff Gauthier; Roger C Levesque; Gee W Lau
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.